Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Flaherty

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Circulation|April 1, 1989
Clot-selective coronary thrombolysis with pro-urokinaseJ Loscalzo, T P Wharton, J M Kirshenbaum, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Circulation|May 1, 1994
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarctionJ T Flaherty, B Pitt, J W Gruber, et al.
The American Journal of Cardiology|October 15, 1995
Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarctionS P Schulman, J L Weiss, L C Becker, et al.
Journal of the American College of Cardiology|August 1, 1985
Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplastyE J Topol, J L Weiss, J A Brinker, et al.
Circulation|September 1, 1983
A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarctionJ T Flaherty, L C Becker, B H Bulkley, et al.
The New England Journal of Medicine|December 24, 1987
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplastyA D Guerci, G Gerstenblith, J A Brinker, et al.
British Heart Journal|April 1, 1988
Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trialS O Gottlieb, L C Becker, J L Weiss, et al.
The New England Journal of Medicine|April 15, 1982
Nifedipine in unstable angina: a double-blind, randomized trialG Gerstenblith, P Ouyang, S C Achuff, et al.
Oral Oncology|June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancerL P Stabile, A M Egloff, M K Gibson, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Circulation|April 1, 1989
Clot-selective coronary thrombolysis with pro-urokinaseJ Loscalzo, T P Wharton, J M Kirshenbaum, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Circulation|May 1, 1994
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarctionJ T Flaherty, B Pitt, J W Gruber, et al.
The American Journal of Cardiology|October 15, 1995
Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarctionS P Schulman, J L Weiss, L C Becker, et al.
Journal of the American College of Cardiology|August 1, 1985
Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplastyE J Topol, J L Weiss, J A Brinker, et al.
Circulation|September 1, 1983
A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarctionJ T Flaherty, L C Becker, B H Bulkley, et al.
The New England Journal of Medicine|December 24, 1987
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplastyA D Guerci, G Gerstenblith, J A Brinker, et al.
British Heart Journal|April 1, 1988
Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trialS O Gottlieb, L C Becker, J L Weiss, et al.
The New England Journal of Medicine|April 15, 1982
Nifedipine in unstable angina: a double-blind, randomized trialG Gerstenblith, P Ouyang, S C Achuff, et al.
Oral Oncology|June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancerL P Stabile, A M Egloff, M K Gibson, et al.
Pageof 12